PBYI

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2009, for Innovative Acquisitions Corp. (Note: The input metadata references "PUMA BIOTECHNOLOGY, INC.", but the filing text explicitly identifies the registrant as Innovative Acquisitions Corp.). The company is a Delaware corporation classified as a "shell company" and a "blank check" company. It was formed to pursue a business combination through the acquisition of or merger with an operating business. Since its inception on April 27, 2007, the company has engaged only in organizational efforts and obtaining initial financing, with no active operations or revenue generation.

Key Financial Metrics

Capital Structure: As of August 11, 2009, there were 3,000,000 shares of common stock outstanding. During the six months ended June 30, 2009, the company received capital contributions of $12,550 from directors, with no new shares issued.

Material Changes Versus Prior Period

• Net Loss: The net loss for the six months ended June 30, 2009, was $10,216, compared to $7,866 for the same period in 2008. This increase is attributed to legal, accounting, and audit fees associated with filing the 2008 Annual Report (Form 10-K) and the Q1 2009 Quarterly Report (Form 10-Q).
• Liquidity: Cash increased from $73 at December 31, 2008, to $2,437 at June 30, 2009. This increase was driven by $12,550 in capital contributions from existing stockholders, which offset the cash burn from operations.
• Liabilities: Accounts payable increased slightly from $2,249 to $2,279.

Outlook, Risks, and Management Commentary

Going Concern: The filing explicitly states that the company has not generated revenue since inception and is unlikely to do so in the immediate future. The continuation of the company as a going concern is dependent upon financial support from shareholders and the ability to obtain necessary equity financing. These factors raise substantial doubt regarding the company's ability to continue as a going concern.

Business Plan: The company intends to identify and acquire a target business. It does not restrict potential targets to any specific industry or location. Management anticipates incurring costs related to filing Exchange Act reports and investigating potential acquisitions over the next 12 months.

Risks: The company faces significant risks inherent in "blank check" companies, including the inability to find a suitable acquisition target, the potential for acquiring financially unstable entities, and the reliance on related parties for funding. There is no assurance that a business combination will be achieved.

Controls and Procedures: Management concluded that disclosure controls and procedures were effective as of June 30, 2009. No material changes in internal controls were reported.

Key Facts for Investor Verification

• Shell Status: Verify the company's status as a shell company with no operations and no revenue, relying entirely on capital contributions to survive.
• Capital Dependency: Confirm the reliance on directors and existing stockholders for the $12,550 capital contribution that funded the period's operations.
• Going Concern Risk: Assess the substantial doubt regarding the company's ability to continue operations without further financing or a successful merger.
• Expense Drivers: Note that all expenses are related to regulatory compliance (legal, accounting, audit fees) rather than business development or product creation.
• Share Count: Verify that no new shares were issued during the period despite the capital infusion; the share count remains at 3,000,000.